Market revenue in 2024 | USD 560.4 million |
Market revenue in 2030 | USD 899.7 million |
Growth rate | 8.2% (CAGR from 2025 to 2030) |
Largest segment | Reagents product |
Fastest growing segment | Others Product |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments Product, Reagents Product, Others Product |
Key market players worldwide | Abbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.
Reagents product was the largest segment with a revenue share of 67.79% in 2024. Horizon Databook has segmented the India infectious disease molecular diagnostics market based on instruments product, reagents product, others product covering the revenue growth of each sub-segment from 2018 to 2030.
Growth in consumer awareness, increase in prevalence of infectious diseases, and rise in disposable income are driving infectious diseases molecular diagnostics market in India. Consumer awareness has led to an increase in the number of tests & diagnostics for infectious diseases over the past few years in the country.
Most common infections in India are Sexually Transmitted Diseases (STDs), VAP, TB, and HAIs. The well-distributed network of clinical laboratories in the country is leading to an easy & faster adoption of infectious diseases molecular diagnostics.
Although earlier molecular diagnostics testing was affordable only to the upper class, rapid economic development of the country has raised the purchasing capacity of people, thereby increasing market penetration of infectious diseases molecular diagnostics in India.
Horizon Databook provides a detailed overview of country-level data and insights on the India infectious disease molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into India infectious disease molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account